KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Oct 14, 2026 - 11:19AM >>  ABB India 7000  [ 0.43% ]  ACC 1142.05  [ 0.43% ]  Ambuja Cements 349.4  [ -0.21% ]  Asian Paints 2361.9  [ 0.04% ]  Axis Bank 1274.9  [ 0.46% ]  Bajaj Auto 10335  [ 0.84% ]  Bank of Baroda 231.6  [ -2.53% ]  Bharti Airtel 1807.45  [ 0.07% ]  Bharat Heavy 444.1  [ 0.48% ]  Bharat Petroleum 287  [ 0.07% ]  Britannia Industries 4847.5  [ 0.95% ]  Cipla 1315.5  [ -1.09% ]  Coal India 416.1  [ 1.74% ]  Colgate Palm 1790.45  [ -0.42% ]  Dabur India 379.75  [ 0.20% ]  DLF 673.05  [ 1.36% ]  Dr. Reddy's Lab. 1222.85  [ -1.36% ]  GAIL (India) 167.1  [ -0.77% ]  Grasim Industries 2896  [ -0.79% ]  HCL Technologies 1337  [ 1.21% ]  HDFC Bank 713.55  [ -0.09% ]  Hero MotoCorp 5014.3  [ 0.29% ]  Hindustan Unilever 1894.85  [ 1.03% ]  Hindalco Industries 896.55  [ -0.43% ]  ICICI Bank 1351  [ -0.68% ]  Indian Hotels Co. 724.3  [ 0.04% ]  IndusInd Bank 878.75  [ 0.31% ]  Infosys 1087.95  [ 2.42% ]  ITC 260.8  [ -0.10% ]  Jindal Steel 1031.1  [ 0.13% ]  Kotak Mahindra Bank 443  [ 0.91% ]  L&T 3647.45  [ -0.75% ]  Lupin 1935  [ -1.28% ]  Mahi. & Mahi 2835.6  [ -0.96% ]  Maruti Suzuki India 11326.8  [ 0.64% ]  MTNL 24.1  [ 0.08% ]  Nestle India 1368.4  [ 2.81% ]  NIIT 83.99  [ -0.23% ]  NMDC 71.65  [ 0.28% ]  NTPC 311.65  [ 0.11% ]  ONGC 224.4  [ 0.85% ]  Punj. NationlBak 115.7  [ -0.73% ]  Power Grid Corpn. 248.55  [ -0.78% ]  Reliance Industries 1173.5  [ 0.58% ]  SBI 950.15  [ -0.60% ]  Vedanta 253.45  [ -1.38% ]  Shipping Corpn. 291  [ 3.43% ]  Sun Pharmaceutical 1751.3  [ -1.01% ]  Tata Chemicals 634.95  [ 0.87% ]  Tata Consumer 974.35  [ 1.39% ]  Tata Motors Passenge 284.1  [ -0.66% ]  Tata Steel 175.4  [ 0.40% ]  Tata Power Co. 349.7  [ 1.38% ]  Tata Consult. Serv. 2317  [ 2.21% ]  Tech Mahindra 1555.75  [ 0.89% ]  UltraTech Cement 10812.55  [ 0.95% ]  United Spirits 1374.05  [ 0.80% ]  Wipro 171  [ 1.24% ]  Zee Entertainment 73.99  [ -0.19% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    MANKIND PHARMA LTD.

    14 October 2026 | 11:09

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE634S01028 BSE Code / NSE Code 543904 / MANKIND Book Value (Rs.) 408.44 Face Value 1.00
    Bookclosure 08/08/2025 52Week High 2642 EPS 46.31 P/E 50.47
    Market Cap. 96549.29 Cr. 52Week Low 1910 P/BV / Div Yield (%) 5.72 / 0.04 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    The Company was incorporated on July 3, 1991 as a private limited company under the Companies Act, 1956, with the name "Mankind Pharma Private Limited", pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Haryana, at New Delhi ("RoC"). Pursuant to the conversion of the Company to a public limited company and as approved by the Shareholders pursuant to a special resolution dated July 14, 2005 the name of the Company was changed to "Mankind Pharma Limited" and the RoC issued a fresh certificate of incorporation on April 13, 2006.

    Major events and milestones:

    2004 
    -Entered the chronic pharmaceutical segment with the launch of `Amlokind' tablets and `Glimestar' tablets amongst others

    2005 
    -Set up the first manufacturing facility at Paonta Sahib, Himachal Pradesh
    -Entered the ophthalmic pharmaceutical segment with the launch of `Lubistar Eye Drops' and `Tobastar Eye Drops' amongst others

    2007 
    -Entered the consumer healthcare segment with the launch of `Manforce' brand
    -Entered the animal healthcare segment with launch of `Bandykind' and `Ceftiforce' amongst othersRaised Rs.720 million from Monet Limited

    2009 
    -Set up the manufacturing facility at Unit II, Paonta Sahib, Himachal Pradesh

    2010 
    -Launched `Preganews' brand in the consumer healthcare segment

    2012 
    -Setup the first R&D centre at IMT Manesar, Haryana

    2014 
    -Acquired Shree Jee Laboratory Private Limited (along with its API manufacturing site situated at Behror, Rajasthan)
    -Set up the manufacturing facility at Unit III, Paonta Sahib, Himachal Pradesh

    2015 
    -Incorporated the Subsidiary, Lifestar Pharma LLC in the US
    -Incorporated the Subsidiary, Mankind Pharma Pte. Limited in Singapore

    2017 
    -Set up the manufacturing facility in Sikkim

    2018 
    -The manufacturing facility at Paonta Sahib, Himachal Pradesh was inspected by the USFDA for the first time

    2019 
    -Entered the female infertility segment with the launch of `Dydroboon' tablets

    2020 
    -Incorporated the Subsidiary, Lifestar Pharmaceuticals Private Limited in Nepal
    -Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of `Cilaheart' tablets and `Statpure' tablets
    -Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of `Zukanorm' tablets

    2021 
    -Incorporated the Subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE
    -Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of `Mlife' tablets
    -Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of `Trugaba-NT' tablets and `Prebris-MNT' tablets

    2022 
    -Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited
    -Entered into transplant segment with the launch of `Pangraf Capsules' and `Mycept' tablets amongst others
    -Entered into oncology segment with the launch of `Pacliall' injection amongst others
    -Acquired the brands `Daffy' and `Combihale' from Dr. Reddy's Laboratories
    -The Subsidiary, Mankind Life Sciences Private Limited acquired 90.00% of the issued, subscribed and paid-up share capital of Upakarma Ayurveda Private Limited.

    2023
    -Mankind Pharma Sets New Industry Standard with Unprecedented Display on Burj Khalifa, Reinforcing Commitment to Excellence.
    -Mankind Pharma announced its partnership with SpiceJet to raise awareness about DMF-grade API.
    -Mankind Pharma Product Prega News and Sonam Kapoor partners to transform from pregnancy detection card to pregnancy care solution.

    2024
    -Mankind Pharma Completes Landmark Acquisition of BSV.
    -Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab.
    -Mankind Pharma Launches 45-Day Healthcare Mission at Mahakumbh Serving Thousands of Pilgrims with Free Health Check-ups.
    -Mankind Pharma Prodct Healthok has joined hands with Bikanervala, (Multinational Indian Restaurant and Sweets Chain).

    2025
    -The Scheme of Arrangement for Amalgamation amongst Shree Jee Laboratory Private Limited , JPR Labs Private Limited  and Jaspack Industries Private Limited  with Mankind Pharma Limited

    Shriram Financial Services Private Limited (Formerly known as Way2Wealth Brokers Pvt. Ltd.) - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Shriram Financial Services Pvt. Ltd. (Formerly known as Way2Wealth Brokers Pvt. Ltd.) All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute